Exploring the Antiemetic Potential of Caffeic Acid: A Combined In Vivo and Computational Approach
Neurogastroenterology & Motility · 2025
DOI: 10.1111/nmo.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurogastroenterology & Motility, 2025. Verfasst von Md Shimul Bhuia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Antiemetics, Caffeic Acids, Vomiting. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: King Saud University.
Abstract (Originalsprache)
Background
This study emphasizes evaluating the antiemetic efficacy of the natural food component caffeic acid (CAF) using a copper sulfate pentahydrate (CuSO 4 .5H 2 O)‐induced emetic model on chicks, and an in silico approach was also adopted to estimate the possible underlying mechanisms.
Methods
Two doses (25 and 50 mg/kg b.w.) of CAF and several referral drugs considered positive controls (PCs), including domperidone (6 mg/kg), hyoscine (21 mg/kg), aprepitant (16 mg/kg), diphenhydramine (10 mg/kg), and ondansetron (5 mg/kg), were orally administered to chicks. The vehicle served as the control group. Co‐treatments of CAF with referral drugs were also provided to chicks to evaluate the modulatory action of the test compound.
Results
According to the results, CAF delayed the emetic onset and decreased the frequency of retches in a dose‐dependent manner compared to the vehicle group. CAF (40 mg/kg) represented a notable delayed latency period (60.17 ± 3.16 s) and a diminished number of retchings (18.33 ± 1.74 times) compared to the control group. Further, in the co‐treatments, CAF increased the latency period and reduced the number of retches, except for domperidone. In the in silico investigation, CAF showed notable binding affinity toward the D 2 (−7.3 kcal/mol), 5HT 3 (−7.1 kcal/mol), and M 5 (−7 kcal/mol) receptors in the same binding site as the referral ligand.
Conclusion
This research indicated that CAF has mild antiemetic properties by interacting with the D 2 , 5TH 3 , and M 5 receptors. Therefore, several preclinical and clinical studies are necessary to assess the effectiveness and safety profile of this food ingredient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Dhaka, Bangladesh.
- Bioinformatics and Drug Innovation Laboratory, BioLuster Research Center Ltd., Dhaka, Bangladesh.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
- Department of Drug Science and Technology, University of Turin, Turin, Italy.
- Pharmacy Discipline, Khulna University, Khulna, Bangladesh.
ORCID-Profile: Md Shimul Bhuia, Raihan Chowdhury
Förderung
- King Saud University
Zitieren
APA
Bhuia, M. S., Ferdous, J., Chowdhury, R., Ansari, S. A., Ansari, I. A., Al Hasan, M. S., Sheikh, S., & Islam, M. T. (2025). Exploring the Antiemetic Potential of Caffeic Acid: A Combined In Vivo and Computational Approach. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.70003
Vancouver
Bhuia MS, Ferdous J, Chowdhury R, Ansari SA, Ansari IA, Al Hasan MS, et al. Exploring the Antiemetic Potential of Caffeic Acid: A Combined In Vivo and Computational Approach. Neurogastroenterology & Motility. 2025. doi:10.1111/nmo.70003
BibTeX
@article{Bhuia2025,
author = {Bhuia, Md Shimul and Ferdous, Jannatul and Chowdhury, Raihan and Ansari, Siddique Akber and Ansari, Irfan Aamer and Al Hasan, Md Sakib and Sheikh, Salehin and Islam, Muhammad Torequl},
title = {Exploring the Antiemetic Potential of Caffeic Acid: A Combined In Vivo and Computational Approach},
journal = {Neurogastroenterology & Motility},
year = {2025},
doi = {10.1111/nmo.70003}
}
EUVIMED